The Combination of New Immunotherapy and Radiotherapy: A N ew Potential Treatment for Locally Advanced Non-Small Cell Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|12|1|4-10

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.12, Iss.1, 2017-06, pp. : 4-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-line Treatment of Advanced Non-small Cell Lung Cancer Non-oncogene Addicted: New Treatment Algorithm in the Era of Novel Immunotherapy

By  

Current Clinical Pharmacology, Vol. 13, Iss. 2, 2018-05 ,pp. : 76-84

Bentham Science Publishers

Access to resources Recommend Favorite

Crizotinib: In Locally Advanced or Metastatic Non-Small Cell Lung Cancer

By Curran Monique P.  

Drugs, Vol. 72, Iss. 1, 2012-01 ,pp. : 99-107

Adis International

Access to resources Recommend Favorite

Gefitinib: A Review of its Use in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer

By Sanford Mark   Scott Lesley J.  

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2303-2328

Adis International

Access to resources Recommend Favorite

Role of taxanes in the combined modality treatment of patients with locally advanced non-small cell lung cancer

By Choy Hak   Pyo Hongryull   Kim Jae-sung   MacRae Rob  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 963-974

Informa Healthcare

Access to resources Recommend Favorite

The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

By  

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 67-73

Bentham Science Publishers

Access to resources Recommend Favorite